Clinical Trial Update: Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating Oncaspar and three doses of pegylated recombinant asparaginase in adults with newly diagnosed acute lymphoblastic leukemia was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Oncaspar (pegaspargase)
• Pegaspargase (pegaspargase)

Snippet

Sponsor: medac GmbH | Conditions: Acute Lymphoblastic Leukaemia | Phase 1, Phase 2 | Status: TERMINATED